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A B S T R A C T
Recently, Vitamin D (Vit. D) has gained importance in cellular functions of a wide range of extraskeletal
organs and target tissues, other than bone. In particular, Vit. D has displayed important beneficial effects
in the cardiovascular system. Although little is known about the mechanism by which this response is
exerted, a Vit. D-induced eNOS-dependent nitric oxide (NO) production in endothelial cells (EC) has been
reported. The aim of this study was to evaluate whether Vit. D administration could affect human EC
proliferation and/or migration through NO production. For this purpose, HUVEC (human umbilical vein
endothelial cells) were used to evaluate Vit. D effects on cell proliferation and migration in a 3D matrix.
Experiments were also performed in the presence of the specific VDR ligand ZK159222 and eNOS
inhibitor L-NAME. This study demonstrated that Vit. D can promote both HUVEC proliferation and
migration in a 3D matrix. These effects were NO dependent, since HUVEC proliferation and migration
were abrogated along with Vit. D induced MMP-2 expression by inhibiting eNOS activity by L-NAME.
These findings support the role of Vit. D in the angiogenic process, suggesting new applications for Vit. D
in tissue repair and wound healing.
ã 2015 Elsevier Ltd. All rights reserved.
1. Introduction
Classically, the active form of vitamin D, 1a,25(OH)2D3 (Vit. D),
is involved in the control of calcium and phosphate homeostasis,
hormonal secretions, cell proliferation and differentiation. More-
over, Vit. D has been found to affect a wide range of extraskeletal
organs and target tissues, including the heart and the vasculature,
with a beneficial effect on cardiovascular function [1–4]. Indeed,
Vit. D insufficiency/deficiency are associated with myocardial
infarction, congestive heart failure and calcific aortic stenosis,
which can lead to themassive vascular calcification seen in chronic
kidney disease [2]. Endothelial cells (EC) are capable of synthesiz-
ing Vit. D due to the expression of the key biosynthetic enzyme 25
(OH)D3-1a-hydroxylase [5]. Moreover, EC also expressed the
intracellular Vit. D Receptors (VDR), suggesting a possible
autocrine/intracrine mechanism exerted by Vit. D as a modulator
of endothelial functions [1,3,6]. Although the beneficial effects of
Vit. D in the cardiovascular system are well established [7–11],
little is known about the mechanisms by which this response is
exerted. Nevertheless, our previous study demonstrated that Vit. D
interactionwith VDR induced nitric oxide (NO) production through
endothelial nitric oxide synthase (eNOS) activation in cultured
human endothelial cells [12]. NO plays a critical role in
cardiovascular physiology and angiogenesis, enhancing EC surviv-
al, proliferation and migration [13,14]. Furthermore, it has been
demonstrated that Vit. D is able to stimulate EC proliferation and to
inhibit their apoptosis by increasing NO production in a murine
model [15]. Because of the presence of both Vit. D and VDR in the
EC and the key role of NO in the endothelial physiology, it is
possible to hypothesize an interaction between Vit. D and NO
capable of influencing EC proliferation andmigration. In a previous
work we have already demonstrated a Vit. D dependent
proliferation and migration in a porcine endothelial cell model
[6]. In order to confirm this mechanism also in human endothelial
cells, Vit. D effects were evaluated in human umbilical vein
endothelial cells (HUVEC), a well-known experimental model for
the study of the regulation of endothelial cell functions and
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angiogenesis. In particular, proliferation and migration in a three-
dimensional matrix have been investigated, along with the
possible involvement of NO as a mediator of Vit. D effects.
2. Materials and methods
2.1. Endothelial cell culture
HUVEC, isolated from umbilical cord veins (ATCC), were
cultured in 0.1% gelatin-coated flask with Endothelial Growth
Medium-2 (EGM-2) containing 2% fetal bovine serum (FBS), 0.04%
hydrocortisone, 0.4% hFGF-B, 0.1% VEGF, 0.1% R3-IGF-1, 0.1%
ascorbic acid, 0.1% hEGF, 0.1% GA-1000, 0.1% heparin (all from
Lonza, Walkersville, MD, USA) and maintained at 37 C and 5% CO2
as previously described [16]. For all experiments cells were used
from passage 3 to 6.
2.2. Cell proliferation
In order to evaluate Vit. D influence on cell proliferation, 103
cells were seeded in gelatin-coated 96 well plates and allow to
adhere; then complete medium was changed with low FBS (0.2%)
DMEM medium without phenol red (starvation medium) and
samples were treated with Vit. D (1a,25-dihydroxyvitamin D3,
Catalog Number D1530, SigmaAldrich, St. Louis, MO, USA; 1-10-
100nM, dissolved in ethanol), ethanol (maximum concentration
0.1%), or left untreated. To verify the effective involvement of VDR
in the action mechanism of Vit. D, HUVEC were also treated with
VDR ligand ZK159222 (Bayer Schering Pharma AG, Berlin,
Germany). This Vit. D antagonist was used at the same
concentration as Vit. D, alone or in co-stimulation. Moreover, in
order to evaluate NO involvement in HUVEC proliferation
following Vit. D treatment, some experiments were performed
in the presence of the NOS inhibitor Nv-nitro-L-arginine methyl
ester hydrochloride (L-NAME; Sigma–Aldrich, St. Louis, MO, USA).
L-NAME was dissolved in serum free medium, used at a final
concentration of 1mM as reported in literature [17,18] and added
15min before Vit. D treatment. For all the experiments, after 48h
incubation, cell culture mediumwas removed and cells were fixed
in 3,7% formaldehyde-3% sucrose solution, stained with 1%
toluidine blue solution and samples were photographed at 10
magnification using an optical microscope (Leica ICC50 HD). Cell
proliferationwas evaluated by counting cells in 10 random fields in
3 samples for each experimental condition from 3 different
experiments. Results were expressed as cells/mm2 standard
deviation (S.D.). Moreover, some samples treatedwith Vit. D and L-
NAME were fixed at 24h, stained with crystal violet and
photographed at 20 magnification using an optical microscope
(Leica ICC50 HD) for morphological analysis.
2.3. Three-dimensional matrix migration assay
HUVEC were seeded in 12 well plates and grown in complete
medium to reach a 70 confluent monolayer. The three-
dimensional hydrogel matrix (Epigel B, Epinova Biotech, Novara,
Italy) were lean onto cell monolayers in 250ml of complete
medium containing different Vit. D concentrations (1-10-100nM).
In order to evaluate the involvement of NO synthesis in HUVEC
migration following Vit. D treatment, some experiments were
performed in the presence of L-NAME, alone or in combination
with the most effective Vit. D concentration. To verify the effective
involvement of VDR in migration, some experiments were also
performed in the presence of ZK159222, used at the same
concentration as Vit. D (100nM), alone or in co-stimulation. After
3 days, cell culturemediumwas replacedwith freshmedium. After
7 days, hydrogel samples were fixed in 3,7% formaldehyde-3%
sucrose solution, stained with 2mg/ml of Hoechst 33342 solution
(Sigma Aldrich, St. Louis, MO, USA) to visualize cell nuclei and then
[(Fig._1)TD$FIG]
Fig. 1. HUVEC proliferation. (A) Optical microscopy images of control and Vit. D (1–100nM) treated cells both in absence or presence of ZK159222 and 1mM L-NAME after
48 h of incubation, stained with toluidine blue. Original magnification =10. Scale bar = 125mm. (B) Determination of HUVEC proliferation in the presence of different Vit. D
concentration (1–100nM) and ZK159222 co-stimulation after 48 h of incubation. Results are expressed as n. cells/mm2 S.D. Grey bars = cells without ZK159222 addition;
black bars = cells + ZK159222. One-way ANOVA followed by Bonferroni post-test were used for statistical analysis. ZK= ZK159222. **P<0.01. (C) Determination of HUVEC
proliferation in the presence of different Vit. D concentration (1–100nM) and L-NAME after 48h of incubation. Results are expressed as n. cells/mm2 S.D. Grey bars = cells
without L-NAME addition; black bars = cells + L-NAME. One-way ANOVA followed by Bonferroni post-test were used for statistical analysis. **P<0.01.
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transferred onto glass microscope slides and observed using Leica
DM5500 fluorescencemicroscope. Cell migrationwas evaluated by
counting migrated cells into the 3D matrix. For each experimental
condition, 3 sampleswere analyzed at 10magnification, selecting
10 random fields and results were expressed as n. cell/HPF (high
power microscope field) standard deviation (S.D.).
2.4. Zymography
Conditioned media from HUVEC migrated into the 3D matrix
for 7 days were separated by electrophoresis on SDS-polyacryl-
amide gels containing 0.2% gelatin. Samples were loaded onto
zymograms without denaturation. After running, gels were
washed at room temperature for 2h in 2.5% Triton X-100 solution
and incubated overnight at 37 C in 0.5M Tris–HCl, 0.2M NaCl,
5mM CaCl2 buffer. Gels were then fixed in MetOH/acetic acid
(50:10) solution and stained in 0.5% coomassie blue in MetOH/
Acetic acid (40:10) solution. Images of stained gels were acquired
after appropriate destaining. Gelatinolytic activity was detected as
white bands on a dark blue background and quantified by
densitometric analysis using ImageJ software.
2.5. Reverse transcription-PCR (RT-PCR)
To detect changes in MMP-2 gene expression after Vit. D
stimulation, total RNA was extracted from control and treated
samples (100nM Vit. D, 1mM L-NAME alone or in co-stimulation)
using Ribozol (Amresco, Solon, OH, USA) according to the
manufacturer’s instructions. RNA integrity was assessed using
nanodrop (Thermo Fisher Scientific, Wilmington, DE, USA). Single-
strand cDNA was synthesized from 300ng of total RNA using high
capacity cDNA reverse transcription kit (Applied Biosystems,
Foster City, CA, USA) according to manufacturer’s instructions.
Aliquots of cDNA products were used as templates for PCR
amplification in an automated thermal cycler (Technegene DNA
Thermal Cycler, Techne, UK). The oligonucleotide primers used
were: MMP-2: Forward 5'-TAC AAA GGG ATT GCC AGG AC-3' and
Reverse 5'-GGC AGC CAT AGA AGG TGT TC-3'; b-actin: Forward 5'-
ACACTGTGC CCATCTACGAGGGG-3' and Reverse 5'-ATGATGGAG
TTG AAG GTA GTT TCG TGG AT-3'. RT-PCR runs were performed
with an initial activation step of 4min at 94 C followed by
35 routine cycles. Each cycle included incubation at 94 C for 30 s,
68 C for 30 s and 72 C for 1min. One additional cycle of 72 C for
7min was run to allow trimming of incomplete polymerization.
Control reactions were performed in the absence of cDNA.
Amplified PCR products were separated on 1.8% agarose gel
containing ethidium bromide and visualized by UV illumination.
Images of stained gels were acquired and the levels of MMP-2 and
b-actin PCR products were quantified by densitometric analysis
using ImageJ software. Data were expressed as MMP-2/b-actin
ratio.
2.6. Statistical analysis
Results are expressed as means S.D. of at least 3 independent
experiments for each protocol. One-way ANOVA followed by
Bonferroni post-test were used for statistical analysis. Probability
values of P<0.05 were considered as statistically significant.
3. Results
3.1. Vitamin D induced HUVEC proliferation through a NO dependent
pathway
HUVEC proliferation has been evaluated after 48h in starvation
medium in the presence or absence of Vit. D (1-10-100nM). As
shown in Fig. 1, Vit. D induced a significant increase in cell growth
at all the concentrations tested. In particular, the observed cellular
densities of Vit. D-stimulated samples were at least doubled
compared to untreated samples. Ethanol used as a vehicle for Vit. D
administration did not affect cell proliferation (data not shown).
The stimulation of HUVEC with the VDR ligand ZK159222 caused a
significant decrease in Vit. D induced cell proliferation, confirming
the role of VDR in the effects mediated by Vit. D (Fig. 1B).
Furthermore, in order to evaluate NO involvement in the observed
Vit. D effects, proliferation assays were performed in the presence
of 1mM L-NAME, an arginine analog that inhibits NO synthesis.
Under these conditions, Vit. D was not able to induce cell
proliferation. As shown in Fig. 1C, L-NAME presence did not alter
control HUVEC proliferation, whereas completely reverted Vit. D-
induced cell proliferation. Moreover, some samples treated as
described above were fixed at 24h and photographed for
morphological analysis. Noteworthy, an increase in cell mitosis
has been observed only in Vit. D treated specimens and not in
samples with L-NAME (Fig. 2).
3.2. Vitamin D induced HUVEC migration in a 3Dmatrix through a NO
dependent pathway
HUVEC migration has been evaluated in a three-dimensional
model. A 3D matrix was lain on 70% confluent HUVEC monolayers.
The 3D matrix used in these experiments was an anionic hydrogel
made of gelatin and polyglutamic acid, which was previously
described as a good substrate for cell growth [19,20]. As shown in
[(Fig._2)TD$FIG]
Fig. 2. Cellmitosis. Representative optical images of control and Vit. D-treated cells both in absence or presence of L-NAME after 24h of incubation, stainedwith crystal violet.
Original magnification = 20. Scale bar = 15mm.
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Fig. 3A and B, HUVEC migration increased significantly only in the
presence of 10nM and 100nM Vit. D (P<0.05 and
P<0.01 respectively). In order to evaluate NO involvement in
the observed phenomenon, the same experiments were also
performed stimulating cells with 1mM L-NAME in the presence or
absence of the most effective Vit. D concentration (100nM). As
shown in Fig. 4A and B, L-NAME treatment did not affect control
cells migration, whereas significantly reduced Vit. D-induced
hydrogel invasion (P<0.01 compared to Vit. D alone). To
demonstrate the relevance of VDR on these effects, some experi-
ments were also performed with Vit. D alone or in co-stimulation
with ZK159222. This VDR ligand reduced Vit. D-induced migratory
effect, as shown in Fig. 5.
3.3. Vitamin D induced MMP-2 mRNA expression and gelatinolytic
activity via NO dependent pathway
Extracellular matrix (ECM) degradation is one of the main steps
in cellmigration. For this reasonVit. D effects onMMP-2 expression
have been evaluated both in the conditioned medium of HUVEC
migrating into the 3D hydrogel matrix and in RT-PCR. Gelatin
zymography, performed on conditioned medium after 7 days of
cell migration in the 3D matrix, demonstrated a statistically
significant increase in MMP-2 activity in all the Vit. D treated
samples. This effect was more evident in samples stimulated with
100nM Vit. D (P<0.01). The increase in MMP-2 expression
appeared to be NO dependent, as L-NAME treatment totally
abrogated Vit. D effects on MMP-2 expression (Fig. 6), according to
the above described results for cell migration. In ZK159222-treated
samples, MMP-2 activity reflected the data obtained for the
migration assay (Fig. 7).
To evaluate whether the increased cell density into the 3D
matrix was due to cell proliferation and/or migration, we
investigated Vit. D effects on MMP-2 mRNA expression after
24h of stimulation with the most effective Vit. D concentration
(100nM). As shown in Fig. 8, Vit. Dwas able to induce a statistically
significant increase in MMP-2 mRNA expression, indicating that a
Vit. D induced increase in cell migration is also involved in the
observed process. As expected, L-NAME treatment decreased Vit.
D-induced effects on MMP-2 expression (Fig. 8).
4. Discussion
Vit. D activity is currently of great interest, because its
deficiency is causally associated with musculoskeletal diseases.
Moreover, there has been an increasing interest in the relationship
between Vit. D and extra-skeletal disorders, due to the identifica-
tion of VDR in almost all human cells [10]. In particular, the
[(Fig._3)TD$FIG]
Fig. 3. Vit. D treated HUVECmigration into the 3Dmatrix. (A) Fluorescencemicroscopy images of control and Vit. D (1–100nM) treated cells migrated in the 3Dmatrix after 7
days of incubation, stained with Hoechst 33342. Original magnification = 10X. Scale bar = 10. Scale bar = 60mm. B) Determination of HUVEC migration after 7 days of
incubation in the presence of different concentration of Vit. D (1–100nM). Results are expressed as n. cell/HPF S.D. One-way ANOVA followed by Bonferroni post-test were
used for statistical analysis. *P<0.05; **P<0.01.
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association between Vit. D deficiency and cardiovascular diseases
has been deeply investigated [7,9] and recently Vit. D has been
proposed as a novel and effective approach for vascular regenera-
tion [21]. Concerning angiogenesis, therapeutic modulation of this
process is a new promising field under investigation, since both
macro- and micro-vascular ischaemic diseases remain a major
concern. Indeed, dysregulated angiogenesis is involved in different
pathologies, such as cardiovascular diseases, diabetes and chronic
inflammation [14,22]. Angiogenesis is a multistep process includ-
ing endothelial cell proliferation and migration into surrounding
stroma/tissues. In the present study the effects of Vit. D
administration in HUVEC have been investigated; a first set of
experiments revealed a Vit. D-induced proliferation. Vit. D effects
were actuallymediated byVDR and its involvementwas confirmed
by the absence of increased cell proliferation in the presence of
ZK159222, a VDR antagonist. In a second set of experiments
focused on identifying Vit. D effects on HUVEC migration, a dose-
dependent increase in cell migration in the 3D matrix was found.
Angiogenesis requires the presence of proteases, such as thematrix
metallo-proteinases (MMPs), which can degrade some of the
components of the extracellular matrix (ECM) to let EC migrate
into the surrounding environment. Moreover, MMPs also contrib-
ute to angiogenesis by detaching pericytes from vessels undergo-
ing angiogenesis, by releasing ECM-bound angiogenic growth
factors and by stimulating endothelial cell proliferation [23,24]. In
particular, the main components of the vascular basal lamina
(collagen IV, laminin and fibronectin) are degraded mainly by
MMP-2 and byMMP-9, also known as gelatinases [25]. Considering
the key role ofMMP-2 in ECmigration,MMP-2 expression has been
investigated, both at transcriptional and translational level. For this
purpose, the MMP-2 expression were evaluated by zymography
and by RT-PCR in order to determine whether MMP-2 activation is
involved in themechanism underlying the 3Dmigratory responses
induced by Vit. D. After 7 days of cell migration in the 3D matrix,
MMP-2 activity was significantly increased in Vit. D-treated
samples and the maximum effect was obtained in the presence
[(Fig._4)TD$FIG]
Fig. 4. Vit. D and L-NAME treated HUVEC migration into the 3D matrix. (A) Fluorescence microscopy images of control and Vit. D (100nM) treated cells, both in the absence
and presence of L-NAME, migrated in the 3D matrix after 7 days of incubation and stained with Hoechst 33342. Original magnification = 10X. Scale bar = 60mm. =10. Scale
bar =60mm. (B) Determination of control and Vit. D (100nM) treated cells after 7 daysmigration both in the absence and presence of 1mM L-NAME. Results are expressed as
n. cell/HPF S.D. One-way ANOVA followed by Bonferroni post-test were used for statistical analysis. **P<0.01.
[(Fig._5)TD$FIG]
Fig. 5. Vit. D and ZK159222-treated HUVECmigration into the 3Dmatrix. Determination of control and Vit. D (100nM) treated cells after 7 daysmigration both in the absence
and presence of ZK159222. Results are expressed as n. cell/HPF S.D. One-way ANOVA followed by Bonferroni post-test were used for statistical analysis. *P<0.05.
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of 100nMVit. D. To demonstrate VDR involvement on these effects,
some samples were co-stimulated with Vit. D and ZK159222. This
VDR ligand reduced Vit. D-induced migratory effect. To determine
whether cells counted into the 3D matrix were all actually
migrated or only a small population was migrated and subse-
quently proliferated, we investigated theMMP-2mRNAexpression
after 24h of stimulation with the most effective Vit. D concentra-
tion (i.e. 100nM). Vit. D was able to induce an increase in MMP-
2 expression regardless of cell proliferation, suggesting a combined
and simultaneous action between enhanced proliferation and
migration. Furthermore, L-NAME treatment did not affect control
MMP-2 expression, whereas significantly reduced Vit. D-induced
effects.
Endothelium derived NO is a bioregulatory molecule that
controls the vascular tone and it is a critical mediator of angiogenic
process [26,27]. NO exerts its pro-angiogenic effects by enhancing
EC survival, proliferation and migration, and inducing the
expressions of VEGF and FGF from vascular cells leading to an
increase in angiogenic stimuli [14]. Since Vit. D was previously
described as being able to induce NO production in HUVEC culture
[(Fig._6)TD$FIG]
Fig. 6. MMP-2 activity in Vit. D and L-NAME-treated HUVEC. (A) Representative zymography of cell growth medium from Vit. D treated HUVEC migrated into the 3D matrix
for 7 days in the absence or presence of L-NAME. (B) Densitometric quantification of MMP-2 expression. One-way ANOVA followed by Bonferroni post-test were used for
statistical analysis. *P<0.05; **P<0.01.
[(Fig._7)TD$FIG]
Fig. 7. MMP-2 activity in Vit. D and ZK159222-treated HUVEC. Densitometric quantification of MMP-2 expression. One-way ANOVA followed by Bonferroni post-test were
used for statistical analysis. *P<0.05.
40 P. Pittarella et al. / Journal of Steroid Biochemistry & Molecular Biology 149 (2015) 35–42
through eNOS activation [12], a possible NO involvement in the
proliferative and migratory effects induced by Vit. D can be
hypothesized. For this purpose, further experiments were per-
formed in the presence of L-NAME, an eNOS competitive inhibitor.
As expected, L-NAME was able to prevent Vit. D-induced cell
proliferation and migration, drastically reducing cell number.
Moreover, L-NAME caused a dramatic reduction in MMP-2 activity
confirming the involvement of NO as a mediator of Vit. D effects.
5. Conclusions
The results described herein highlight that Vit. D stimulated
human EC proliferation and migration in a 3D matrix through NO-
dependent mechanisms. These findings strongly support the role
of Vit. D in human angiogenic process, suggesting newapplications
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